Gentiva Health (GTIV) PT Reduced to $8.50 at Deutsche Bank Following Soft Q4
Tweet Send to a Friend
Deutsche Bank maintained a Hold rating on Gentiva Health Services (NASDAQ: GTIV) and lowered its price target to $8.50 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
